Launch of New Research Project “AIRIS”: Developing an AI Research Collaborator to Advance Biomedical Research
AIRIS unites 21 partners from Europe, Canada and the US to develop generative AI models that integrate biological knowledge and clinical data. AIRIS’ main goal is to deliver an AI collaborator that helps researchers better understand disease progression and advance personalised medicine.
AutoPiX Project Celebrates European Patent Grant to Singularity Biomed for its AI Thermal-Imaging Technology
European patent strengthens the role of AI-powered thermography in the future of rheumatology and reinforces AutoPiX’s innovation ecosystem
TWIN-X Project Launches with €15 Million in EU Funding to Advance Patient-Centred Medicine through Trustworthy Digital Twins
The newly launched TWIN-X project aims to use the power of artificial intelligence (AI) to combine these diverse data sources and create a virtual copy of a patient, known as a digital twin.
ImmUniverse Advances Multi-Omics Research and Patient-Centred Innovation
As the ImmUniverse project approaches its conclusion, the consortium is reflecting on several years of collaborative research dedicated to improving the understanding and management of immune mediated diseases, with a particular focus on ulcerative colitis and atopic dermatitis.
EULAR 2026 Highlights the Power of Collaboration in Rheumatology Research Across our HEALTH Innovation Ecosystem
EULAR 2026, the largest European congress in rheumatology, once again served as a leading global meeting point for researchers, clinicians, patient representatives, policymakers, and industry leaders working to advance care and innovation in rheumatic and musculoskeletal diseases.
From Research to Patient Empowerment: miGUT-Health Releases ENGAGE-IBD Guide
For people living with chronic conditions, managing health extends far beyond medical appointments. It involves understanding symptoms, making informed decisions, communicating with healthcare professionals, and navigating everyday challenges.
REALM Academy Patient Workshop brings patient perspectives into Medical AI discussions
On 19 March 2026, the REALM project welcomed representatives from patient organisations and disease-oriented medical research charities across Europe to Brussels for a dedicated stakeholder workshop.
Early Diagnosis, Real Impact: How Screen4Care Is Shaping Rare Disease Care in Europe
Every rare disease journey begins somewhere—but too often, diagnosis comes too late. On "Rare Disease Day", we spoke with Prof. Alessandra Ferlini, Scientific Coordinator of Screen4Care and Professor at the University of Ferrara, about how genetic newborn screening could help change this reality.
MuSiC4Diabetes at Diatec 2026 in Berlin
On 23 January, MuSiC4Diabetes was featured in the Diatec panel “Breakthrough Projekte aus der DACH-Region” (Breakthrough Projects from Germany, Austria and Switzerland), chaired by Norbert Hermanns (FIDAM) and Peter Diem (Diabetesschweiz).
Early AMD screening made more accessible with I-SCREEN
Age-related macular degeneration (AMD) is one of the leading causes of vision loss after the age of 50, often progressing without noticeable symptoms in its early stages.
Strengthening Preparedness for Future Epidemics
On the International Day of Epidemic Preparedness, the NoVir project highlights the importance of proactive antiviral development and collaboration to better protect global health.
Yscript Delivers Proof-of-Concept for Yeast-based mRNA Production – A Milestone on the Road to Scalable, Affordable Therapeutics
The EIC-funded Yscript project, running from April 2022 to September 2025, has successfully demonstrated the proof-of-concept for producing messenger RNA (mRNA) using yeast cells, marking a significant milestone and paving the way for a groundbreaking shift in mRNA manufacturing.
Health